Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.

Gerbes, Alexander; Zoulim, Fabien; Tilg, Herbert; Dufour, Jean-François; Bruix, Jordi; Paradis, Valérie; Salem, Riad; Peck-Radosavljevic, Markus; Galle, Peter R; Greten, Tim F; Nault, Jean-Charles; Avila, Matias A (2018). Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut, 67(2), pp. 380-388. BMJ Publishing Group 10.1136/gutjnl-2017-315068

Text 380.full.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy

Hepatocellular carcinoma (HCC) ranks number three among the most frequent causes of death from solid tumors worldwide. With obesity and fatty liver diseases as risk factors on the rise, HCC represents an ever increasing challenge. While there is still no curative treatment for most patients numerous novel drugs have been proposed, but most ultimately failed in phase III trials. This manuscript targets therapeutic advances and most burning issues. Expert key point summaries and urgent research agenda are provided regarding risk factors, including microbiota, need for prognostic and predictive biomarkers and the equivocal role of liver biopsy. Therapeutic topics highlighted are locoregional techniques, combination therapies and the potential of immunotherapy. Finally the manuscript provides a critical evaluation of novel targets and strategies for personalized treatment of HCC.

Interest & Impact

Downloads

1 since deposited on 06 Apr 2018
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item